Brazil‘s health regulator Anvisa on Friday approved imports of Russia’s Sputnik V and India’s Covaxin COVID-19 vaccines, but subject to circumstances on both.

Now, the 4-1 vote by Brazilian health regulator’s board follows rulings in April to reject Brazilian states’ request for Sputnik V due to a lack of data guaranteeing its safety, quality and effectiveness, and in March to reject Covaxin because it did not meet Anvisa’s manufacturing standards, as reported by Reuters.